Drugs in bottles Drugmakers argue that peer reviews or real-world evidence of the benefits of their drugs should have been included included in the report’s analysis. (Photo: ShutterstocK)

Drug manufacturers in 2017 and 2018 hiked the prices of seven drugs to the tune of $5.1 billion–despite no new clinical evidence the drugs had improved, according to Institute for Clinical and Economic Review’s Unsupported Price Increase Report.

Drugs with unsupported price increases, according to the nonprofit include, Humira, with a 15.9 percent net price increase, resulting in $1,857 of increased spending; Rituxan, 23.6 percent, $806; Lyrica, 22.2 percent, $688; Truvada, 23.1 percent, $550; Neulasta, 13.4 percent, $489; Cialis, 32.5 percent, $403; and Tecfidera, 9.8 percent, $313.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

Katie Kuehner-Hebert

Katie Kuehner-Hebert is a freelance writer based in Running Springs, Calif. She has more than three decades of journalism experience, with particular expertise in employee benefits and other human resource topics.

More from this author


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.